| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.32 | 0.05 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |